Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing the Effect(s) and Safety of Fluoxetine Initiated in the Acute Phase of Stroke

NCT02683213 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02683213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02683213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing the Effect(s) and Safety of Fluoxetine Initiated in the Acute Phase of Stroke
Lead sponsor
Karolinska Institutet
Phase
Phase 3
Overall status
Completed
Start date
October 20, 2014
Completion date
June 30, 2020
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke